Chemotherapy For Medulloblastoma

J Gordon Millichap

doi:10.15844/pedneurbriefs-2-11-9

Chemotherapy For Medulloblastoma

Pediatric Neurology Briefs

Volume 2 (1988): Issue 11

By: J Gordon Millichap

Open Access

|Nov 1988

Abstract

The efficacy of adjuvant chemotherapy for patients with poor-risk medulloblastoma/primitive neuroectodermal tumors (MB/PNET) has been studied at the Children’s Hospital of Philadelphia, University of Pennsylvania, PA.

References

Packer RJ Siegel KR Sutton LN Evans AE D’Angio G Rorke LB Efficacy of adjuvant chemotherapy for patients with poor-risk medulloblastoma: a preliminary report Ann Neurol 1988 Oct 24 4 503 8 10.1002/ana.410240405 3239953
Open DOI Search in Google Scholar Back to article
Groover RV Swaiman KF Wright FS Posterior fossa tumors The practice of pediatric neurology 1982 St. Louis CV Mosby 844 880
Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.15844/pedneurbriefs-2-11-9 | Journal eISSN: 2166-6482

Journal RSS Feed

Language: English

Page range: 86 - 87

Published on: Nov 1, 1988

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

Adjuvant Chemotherapy,

Medulloblastoma/Primitive Neuroectodermal Tumors,

Cyclohexylnitrosourea

© 1988 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 2 (1988): Issue 11